Emergency Department, 305 Hospital of People's Liberation Army, Beijing, People's Republic of China.
Outpatient Department, 305 Hospital of People's Liberation Army, Beijing, People's Republic of China.
Medicine (Baltimore). 2024 Aug 2;103(31):e39194. doi: 10.1097/MD.0000000000039194.
Splenic abscess is relatively rare in clinical practice as an invasive disease. However, during the continuous prevalence of coronavirus disease 2019 (COVID-19), the incidence rate of splenic abscess showed an upward trend. However, because the etiology of splenic abscess is not specific, it is easy to be covered by the respiratory symptoms of COVID-19, resulting in omission or delay in diagnosis. If splenic abscesses cannot be treated in a timely manner, the mortality rate can reach 100%. Therefore, it is important to fully understand the correlation between COVID-19 and the development of splenic abscesses.
A female patient, 71 years of age, was admitted to our hospital because of cough and sputum for 1 week and fever for 2 days. According to the positive results of novel coronavirus nucleic acid and chest computed tomography, novel coronavirus pneumonia was diagnosed. On the 4th day after treatment, abdominal distension and vomiting were observed. Abdominal ultrasound indicated splenomegaly and mixed echo masses in the spleen and abdominal computed tomography indicated 2 new round low-density lesions were found in the spleen.
The patient was diagnosed with secondary splenic abscess after COVID-19 infection.
The patient and her family members refused to undergo ultrasound-guided splenic puncture drainage and splenectomy. In terms of treatment, she was given meropenem combined with vancomycin to continue anti-infection treatment.
The patient's body temperature and infection indicators gradually increased, and the scope of splenic abscess continued to expand. The infection worsened and progressed to septic shock. The patient abandoned rescue drugs and invasive treatment, and died on the 9th day after admission.
This case introduces the clinical characteristics of secondary splenic abscess caused by COVID-19 from the aspects of etiology, disease course, clinical manifestations, auxiliary examinations, and treatment methods. The focus is on improving the understanding of clinical doctors about secondary splenic abscesses caused by COVID-19, providing reference for early diagnosis and timely treatment.
脾脓肿作为一种侵袭性疾病,在临床实践中相对少见。然而,在 2019 年冠状病毒病(COVID-19)持续流行期间,脾脓肿的发病率呈上升趋势。但是,由于脾脓肿的病因并不特异,容易被 COVID-19 的呼吸道症状所掩盖,导致诊断的遗漏或延迟。如果脾脓肿不能得到及时治疗,死亡率可达到 100%。因此,充分了解 COVID-19 与脾脓肿发展之间的相关性非常重要。
一位 71 岁女性患者,因咳嗽、咳痰 1 周,发热 2 天入住我院。根据新型冠状病毒核酸及胸部 CT 结果,诊断为新型冠状病毒肺炎。治疗第 4 天,患者出现腹胀、呕吐,腹部超声提示脾大,脾内混合回声团块,腹部 CT 提示脾内新增 2 个圆形低密度病灶。
患者在 COVID-19 感染后诊断为继发性脾脓肿。
患者及其家属拒绝行超声引导下脾穿刺引流及脾切除术。治疗上继续给予美罗培南联合万古霉素抗感染治疗。
患者体温及感染指标逐渐升高,脾脓肿范围持续扩大,感染加重进展为感染性休克,患者放弃抢救药物及有创治疗,于入院后第 9 天死亡。
本病例从病因、病程、临床表现、辅助检查、治疗方法等方面介绍了 COVID-19 继发脾脓肿的临床特点,重点在于提高临床医生对 COVID-19 继发脾脓肿的认识,为早期诊断和及时治疗提供参考。